Medistim ASA (0OCD.L) LSE

225.00

-2(-0.88%)

Updated at October 17 08:16AM

Currency In NOK

Valuation

Market Cap2.75B
Enterprise Value2.6B
P/E Ratio31.04
PEG Ratio4.63
Price/Sales Ratio6.43
Price/Book Ratio10.61
Enterprise/Revenue6.31
Enterprise/EBITDA19.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.21
Operating Margin0.27

Management Effectiveness

Return On Assets0.25
Return On Equity0.31

Income Statement

Revenue556.16M
Revenue/Share34.76
Gross Profit235.39M
EBITDA159.22M
Net Income103.83M
Diluted EPS5.67

Balance Sheet

Total Cash96.35M
Total Cash/Share5.28
Total Debt22.03M
Total Debt/Equity0.06
Current Ratio3.14
Book Value Per Share21.03

Price History

52-Week Change32.35
52-Week High300
52-Week Low177.5
Moving Average 50 Days210.26
Moving Average 200 Days233.84

Statistics

Average Volume98
Shares Outstanding18.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate6
Trailing Annual Dividend Yield2.69
Payout Ratio0.84
Last Split FactorN/A
Last Split DateN/A